Episurf Medical Q1: Slow quarter with eventful horizon

Research Update

2024-04-25

09:43

We note another quarter in which the operations have not yet translated into meaningful sales. We would like to point to two other significant events after the quarter: Its new distribution deal agreement and ongoing rights issue. We have preliminary updated our fair value range and await the completion of the rights issue for further adjustments.

JW

OB

John Westborg

Oscar Bergman

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.